Pacira | PCRX - Passivo Circulante





Passivo Circulante Alterar Data
Astellas Pharma JPY 1.22T 106.19B 2026-03
Bristol-Myers Squibb USD 19.16B 4.26B 2026-03
Cara Therapeutics USD 11.04M 2K 2025-12
Coherus Biosciences USD 140.39M 231.91M 2025-12
Heron Therapeutics USD 90.52M 5.58M 2026-03
Ironwood Pharmaceuticals USD 236.31M 5.91M 2026-03
J&J USD 57.72B 3.59B 2026-03
Ligand Pharmaceuticals USD 40.67M 3.22M 2026-03
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Novo Nordisk DKK 225.16B 9.5B 2026-03
Omeros USD 85.5M 2.28M 2025-06
Pacira USD 108.79M 11.8M 2026-03
Perrigo USD 997.6M 15.3M 2026-03
Pfizer USD 34.35B 2.64B 2026-03
Supernus Pharmaceuticals USD 373.93M 35.76M 2026-03
Teva Pharmaceutical Industries USD 13.53B 76M 2026-03
Xeris Pharmaceuticals USD 118.59M 9.02M 2026-03
Xoma USD 28.3M 6.81M 2025-09
Zoetis USD 2.05B 182M 2026-03